首页> 外文期刊>Water Research >Investigating norovirus removal by microfiltration, ultrafiltration, and precoagulation-microfiltration processes using recombinant norovirus virus-like particles and real-time immuno-PCR
【24h】

Investigating norovirus removal by microfiltration, ultrafiltration, and precoagulation-microfiltration processes using recombinant norovirus virus-like particles and real-time immuno-PCR

机译:研究使用重组诺如病毒样颗粒和实时免疫PCR通过微滤,超滤和预凝微滤过程去除诺如病毒

获取原文
获取原文并翻译 | 示例
           

摘要

The removal of microorganisms by drinking water treatment processes has been widely investigated in laboratory-scale experiments using artificially propagated microorganisms. However, this approach cannot be applied to norovirus removal, because this virus does not grow in cell or organ culture, and this fact has hampered our ability to investigate its behavior during drinking water treatment. To overcome this difficulty, our research group previously used recombinant norovirus virus-like particles (rNV-VLPs), which consist of an artificially expressed norovirus capsid protein, in laboratory-scale drinking water treatment experiments. However, the enzyme-linked immunosorbent assay (ELISA) method generally used to detect rNV-VLPs is not sensitive enough to evaluate high removal ratios such as those obtained by ultrafiltration (UF). We therefore developed and applied a real-time immuno-polymerase chain reaction (iPCR) assay for rNV-VLP quantification to investigate norovirus removal by microfiltration (MF), UF, and hybrid precoagulation-MF processes. The rNV-VLP detection limit with the developed iPCR assay was improved at least 1000-fold compared with ELISA. Whereas MF with a nominal pore size of 0.1 μm could not eliminate NV-VLPs, a 4-log reduction was achieved by UF with a molecular weight cutoff of 1 kDa. When MF was combined with precoagulation (≥10 μmol-Fe/L for ferric chloride; ≥20 μmol-Al/L for polyaluminum chloride; ≥40 μmol-Al/L for alum), the performance of the hybrid process in eliminating rNV-VLPs was greater than that achieved by the 1 kDa UF. For all processes, the removal ratios of the bacteriophages MS2 and Qβ were greater than the rNV-VLP removal ratios by 1-2 logs, so neither bacteriophage can be recommended as a possible conservative surrogate for predicting the behavior of native NV during these processes.
机译:在使用人工繁殖的微生物的实验室规模的实验中,已经广泛地研究了通过饮用水处理过程去除微生物的方法。但是,这种方法不能应用于诺如病毒的去除,因为这种病毒不会在细胞或器官培养物中生长,并且这一事实阻碍了我们研究饮用水处理过程中其行为的能力。为了克服这一困难,我们的研究小组先前在实验室规模的饮用水处理实验中使用了重组诺如病毒样颗粒(rNV-VLP),该颗粒由人工表达的诺如病毒衣壳蛋白组成。但是,通常用于检测rNV-VLP的酶联免疫吸附测定(ELISA)方法不够灵敏,无法评估高去除率,例如通过超滤(UF)获得的去除率。因此,我们开发并应用了实时免疫聚合酶链反应(iPCR)分析法进行rNV-VLP定量研究,以研究诺如病毒通过微滤(MF),超滤和混合预凝血-MF工艺的去除。与ELISA相比,使用开发的iPCR测定法对rNV-VLP的检测限提高了至少1000倍。而标称孔径为0.1μm的MF无法消除NV-VLP,而UF的截留分子量为1 kDa则可实现4-log的降低。当MF与预凝结合时(三氯化铁≥10μmol-Fe/ L;聚氯化铝≥20μmol-Al/ L;明矾≥40μmol-Al/ L),混合工艺消除了rNV- VLP大于1 kDa UF所获得的VLP。对于所有过程,噬菌体MS2和Qβ的去除率均比rNV-VLP去除率高1-2个对数,因此,两种噬菌体均不能作为可能的保守替代方法推荐用于预测这些过程中天然NV的行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号